Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Tay-Sachs disease screening and diagnosis: evolving technologies.

Hechtman P, Kaplan F.

DNA Cell Biol. 1993 Oct;12(8):651-65. Review.

PMID:
8397824
2.
3.

Heterozygote screening for Tay-Sachs disease: past successes and future challenges.

Natowicz MR, Prence EM.

Curr Opin Pediatr. 1996 Dec;8(6):625-9. Review.

PMID:
9018448
4.

The molecular basis of Tay-Sachs disease: mutation identification and diagnosis.

Mahuran DJ, Triggs-Raine BL, Feigenbaum AJ, Gravel RA.

Clin Biochem. 1990 Oct;23(5):409-15. Review.

PMID:
2147596
5.

Tay-Sachs disease-causing mutations and neutral polymorphisms in the Hex A gene.

Myerowitz R.

Hum Mutat. 1997;9(3):195-208. Review.

PMID:
9090523
6.

Tay-Sachs disease as a model for screening inborn errors.

Blitzer MG, McDowell GA.

Clin Lab Med. 1992 Sep;12(3):463-80. Review.

PMID:
1355703
7.

Biochemistry and genetics of Tay-Sachs disease.

Gravel RA, Triggs-Raine BL, Mahuran DJ.

Can J Neurol Sci. 1991 Aug;18(3 Suppl):419-23. Review.

PMID:
1834320
8.

[Biochemical, molecular and social aspects of carrier screening for Tay-Sachs disease].

Peleg L, Gazit E, Goldman B, Akstein E.

Harefuah. 1995 Dec 1;129(11):475-80. Review. Hebrew. No abstract available.

PMID:
8846957
10.

Biochemical and molecular aspects of late-onset GM2-gangliosidosis: B1 variant as a prototype.

Suzuki K, Vanier MT.

Dev Neurosci. 1991;13(4-5):288-94. Review.

PMID:
1840099
11.

GM2 gangliosidosis with a motor neuron disease phenotype: clinical heterogeneity of hexosaminidase deficiency disease.

Federico A.

Adv Exp Med Biol. 1987;209:19-23. Review. No abstract available.

PMID:
2953177
12.

Tay-Sachs disease: current perspectives from Australia.

Lew RM, Burnett L, Proos AL, Delatycki MB.

Appl Clin Genet. 2015 Jan 21;8:19-25. doi: 10.2147/TACG.S49628. eCollection 2015. Review.

Supplemental Content

Support Center